FDG positron emission tomography in colorectal cancer.
D054598:Blue Cross Blue Shield Insurance Plans; D002921:Cicatrix / Q000000981:diagnostic imaging; D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging*; D018795:Device Approval; D017277:Drug Approval; D005069:Evaluation Studies as Topic; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D017063:Outcome Assessment, Health Care; D019275:Radiopharmaceuticals; D013673:Technology Assessment, Biomedical; D014055:Tomography, Emission-Computed / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18